Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Meclozine Dihydrochloride
Meclozine Hcl · diadril · bonamine · NSC 28728 · Navidoxine · )-4-(3-methyL · Meclizine 2HCl · Meclizine diHCl
식별자 및 물리적 특성
| CAS No. | 1104-22-9 |
|---|---|
| 분자식 | C25H29Cl3N2 |
| 평균 분자량 | 463.9 g/mol |
| 단동위원소 질량 | 462.139632 g/mol |
| SMILES | Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1.Cl.Cl |
| InChIKey | VCTHNOIYJIXQLV-UHFFFAOYSA-N |
| PubChem CID | 64713 |
| ChEMBL | CHEMBL1324020 |
| EC No. | 214-164-8 |
| DTXSID | DTXSID9045348 |
화학 및 물리적 성질
| 극성 표면적 | 6.5 |
|---|---|
| 수소 결합 공여자 수 | 2 |
| 수소 결합 수용자 수 | 2 |
| 회전 가능 결합 수 | 5 |
| 무거운 원자 수 | 30 |
| 형식 전하 | 0 |
| 복잡도 | 447 |
| 녹는점 | 210.0 to 214.0 °C |
| 저장 조건 | 2-8°C |
| 용해도 | DMSO: 용해성5mg/mL, 투명(가온) |
| 물리적 상태 | 가루 |
| 색상 | 흰색에서 베이지색 |
| InChI | 1S/C25H27ClN2.2ClH/c1-20-6-5-7-21(18-20)19-27-14-16-28(17-15-27)25(22-8-3-2-4-9-22)23-10-12-24(26)13-11-23/h2-13,18,25H,14-17,19H2,1H32*1H |
| InChIKey | VCTHNOIYJIXQLV-UHFFFAOYSA-N |
| SMILES | [Cl-].[Cl-].Clc1ccc(cc1)C(N3CCN(CC3)Cc4cc(ccc4)C)c2ccccc2.[H+].[H+] |
| EPA | Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]-, dihydrochloride (1104-22-9) |
화학적 성질
White or yellowish-white, slightly hygroscopic, crystalline powder.
안전 및 규제
| GHS 분류 | WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 44 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| 기타 안전 정보 | IMAP assessments - Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]-, dihydrochloride: Human health tier I assessment |
| Hazard Classes and Categories | Acute Tox. 4 (100%) |
| 수질 위해 등급(WGK) | 3 |
| TSCA 등재 상태 | TSCA listed |
| RTECS 번호 | TL2005000 |
| 독성 | LD50 oral in mouse: 1600mg/kg |
| 관세 코드 | 2933.59.8000 |
| 위험 문구(R) | 22-63 |
| 위험 표시 | Xn |
| 안전 문구(S) | 22-36 |
| 위험 등급 | Acute Tox. 4 OralRepr. 2 |
| 저장 분류 | 11 - Combustible Solids |
용도
개요
Meclizine is a histamine H1 receptor antagonist (Ki = 250 nM). Pretreatment with meclizine (2.5-30 mg/kg, i.p.) reduces ovalbumin-induced mast cell degranulation, edema, and leukocyte influx in rat lung. Formulations containing meclizine have been used in the treatment of motion sickness and vertigo.
용도
Meclizine Dihydrochloride is a histamine H1 receptor antagonist with antiemetic properties. Meclizine Dihydrochloride is a research product for neuroscience. This compound may exhibit neuroprotective properties.